Market Report

Decentralised Clinical Trials Market Report 2026-2036

The global decentralised clinical trials market is projected to grow at a CAGR of 7.6% by 2036

SKU: PHA1386 Category: Code: PHA1386Pages: 385
Clear
← Back to category Contract Services

Description

Visiongain has published a new report, Decentralised Clinical Trials Market Report 2026-2036, providing a comprehensive analysis of the global decentralised clinical trials market, including market size, growth drivers, competitive positioning, and revenue forecasts across key technologies, indications, and end users.

The global decentralised clinical trials market is expected to grow from US$11.3bn in 2026 to US$33.5bn by 2036, at a CAGR of 11.5%, representing a near doubling of the market over the forecast period as decentralised models become embedded in mainstream clinical development.

This growth is driven by continued advancement in digital health technologies, increasing adoption of patient-centric and hybrid trial models, and growing reliance on remote monitoring and real-time data capture to improve trial efficiency and patient engagement.

Access a Free Sample of This Report

Download a sample to explore:

  • Market forecasts and segment breakdowns
  • Competitive and company-level insights
  • Key trends shaping the market
  • Trade, policy, and supply chain analysis

Download Free Sample Report

 

Technological Innovation Driving Market Expansion

Rapid advances in digital health technologies are reshaping the competitive landscape of the decentralised clinical trials market. Wearables, mobile health platforms, and cloud-based systems are enabling continuous, real-time data collection, reducing reliance on traditional site-based assessments and improving trial scalability.

At the same time, integration of AI and advanced analytics is supporting predictive monitoring and adaptive trial design, helping organisations improve data quality, reduce timelines, and enhance decision-making across clinical programmes.

Trade, Policy & Supply Chain Dynamics

  • The decentralised clinical trials market is increasingly influenced by global trade dynamics, regulatory frameworks, and geopolitical developments.
  • The market depends heavily on connected medical devices, sensors, and digital infrastructure, creating exposure to tariffs, export controls, and regulatory variation across key regions.
  • Recent tariff measures on electronics and medical components have increased the cost of trial-enabling technologies, placing pressure on sponsors and contract research organisations and contributing to broader cost uncertainty.
  • In regulated sectors such as pharmaceuticals, compliance with data protection frameworks such as GDPR and HIPAA, alongside approval processes and policy decisions, continues to shape market access and operational execution.

Commercial Impact

  • Cost and pricing pressure: Rising device, technology, and compliance costs are impacting trial budgets
  • Supply chain shifts: Organisations are diversifying sourcing and investing in more resilient digital infrastructure
  • Regulatory influence: Market timelines and access are shaped by evolving global compliance requirements
  • Competitive positioning: Companies aligned with digital innovation and regulatory standards are better positioned

Company Intelligence

The decentralised clinical trials market is characterised by a mix of established technology providers, contract research organisations, and emerging digital health platforms competing across innovation, scalability, and regulatory capability.

Leading companies including Medable, Science 37, IQVIA, and Parexel are strengthening their positions through platform development, strategic partnerships, and expansion into hybrid and fully decentralised trial models.

Competition is increasingly defined by:

  • Technology platform capability and integration
  • Regulatory and data compliance expertise
  • Global operational reach and scalability
  • Ability to support hybrid and patient-centric trial models

At the same time, newer entrants and specialist providers are gaining traction where digital innovation, flexibility, or cost advantage create differentiation.

This report analyses how competitive positioning is evolving, identifying where value is being created and how strategies are expected to shift over the forecast period.

Key Questions Answered

  • What is the projected size of the decentralised clinical trials market by 2036?
  • Which segments and regions will drive growth?
  • How will digital health technologies and hybrid models shape market evolution?
  • How will trade, policy, and supply chain dynamics impact costs and deployment?
  • Who are the leading companies and how will their positions evolve?

Report Scope and Data Coverage

  • Global decentralised clinical trials market analysis
  • Revenue forecasts to 2036
  • Segment-level modelling across study design, indication, technology, and end user
  • Regional and national market forecasts
  • Competitive intelligence on leading companies

Includes both quantitative forecasting and qualitative strategic analysis, covering technology, competition, policy, and supply chain dynamics.

CTA

Segmentation Framework

By Study Design

  • Observational
  • Interventional
  • Expanded Access

By Indication

  • Oncology
  • Cardiovascular
  • Immunology
  • Respiratory
  • Others

By Technology

  • Telemedicine
  • Mobile Healthcare
  • Wearable Devices
  • Web-Based
  • Others

By End-user

  • Pharmaceutical & Biopharmaceutical Companies
  • Clinical Research Organisations
  • Others

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Belgium
  • Switzerland
  • Netherlands
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Taiwan
  • New Zealand
  • Malaysia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Egypt
  • Rest of Middle East & Africa

Decentralised Clinical Trials Market Report 2026-2036
Need industry data? Please contact us today.

Company Intelligence Coverage

This report includes detailed profiles of leading companies such as:

  • 4G Clinical
  • Advarra Inc.
  • Clario
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Science 37
  • Veeva Systems

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Product and technology capabilities
  • Strategic outlook

Bespoke Intelligence & Customisation

Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements.

This includes:

  • Custom market segmentation and forecasts
  • Competitive benchmarking and strategy analysis
  • Policy and regulatory impact assessment
  • Supply chain and sourcing intelligence
  • Scenario modelling including tariffs and geopolitical risk

Speak to our team about bespoke requirements

Why This Market Intelligence Matters

  • The decentralised clinical trials market is evolving rapidly, driven by digital transformation, regulatory change, and shifting clinical development models.
  • Organisations that understand these dynamics will be better positioned to capture growth opportunities, manage risk, and strengthen competitive positioning.

Access the Full Forecast and Competitive Analysis

Purchase the Decentralised Clinical Trials Market Report 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Download sample or contact us for enterprise access

 

For enterprise licensing, customised segmentation or analyst briefings, contact Visiongain directly at contactus@visiongain.com

Government Registration
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Decentralised Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Advancements in Digital Health Technologies
3.3.1.2 Globalisation of Clinical Trials
3.3.1.3 Patient-Centric and Hybrid Trial Models Accelerating Adoption of Decentralised Clinical Trials
3.3.1.4 Evolving Regulatory Support and Guidance
3.3.2 Market Restraining Factors
3.3.2.1 Data Privacy and Security Concerns
3.3.2.2 Technological Limitations and Standardization
3.3.2.3 Infrastructure and Resource Constraints
3.3.3 Market Opportunities
3.3.3.1 Acceleration of Drug Development and Innovation
3.3.3.2 Expansion of Clinical Trial Activities into Emerging Markets
3.3.3.3 Increasing Partnerships and Collaborations Between Pharmaceutical Companies
3.4 U.S. Tariffs: What’s the Impact on Global Decentralised Clinical Trials Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.2.1 Why V-Shaped Recovery?
3.4.2.2 Impact from Tariffs
3.4.2.3 Market Dynamics and Demand Recovery
3.4.2.4 Policy and Funding Support
3.4.2.5 Timeframe for Recovery
3.4.3 U-Shaped Recovery Scenario
3.4.3.1 Why U-Shaped Recovery?
3.4.3.2 Impact from Tariffs
3.4.3.3 Market Dynamics and Demand Recovery
3.4.3.4 Policy and Funding Support
3.4.3.5 Timeframe for Recovery
3.4.4 L Shaped Recovery Scenario
3.4.4.1 Why L-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.4.6 Impact of U.S. and China Trade War on Decentralised Clinical Trials Market
3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitutes
3.5.5 Threat of New Entrants
3.6 PEST Analysis

4 Decentralised Clinical Trials Market Analysis by Study Design
4.1 Key Findings
4.2 Study Design Segment: Market Attractiveness Index
4.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
4.4 Interventional
4.4.1 Market Size by Region, 2026-2036 (US$ Billion)
4.4.2 Market Share by Region, 2026 & 2036 (%)
4.5 Observational
4.5.1 Market Size by Region, 2026-2036 (US$ Billion)
4.5.2 Market Share by Region, 2026 & 2036 (%)
4.6 Expanded Access
4.6.1 Market Size by Region, 2026-2036 (US$ Billion)
4.6.2 Market Share by Region, 2026 & 2036 (%)

5 Decentralised Clinical Trials Market Analysis by Indication
5.1 Key Findings
5.2 Indication Segment: Market Attractiveness Index
5.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
5.4 Oncology
5.4.1 Market Size by Region, 2026-2036 (US$ Billion)
5.4.2 Market Share by Region, 2026 & 2036 (%)
5.5 Cardiovascular
5.5.1 Market Size by Region, 2026-2036 (US$ Billion)
5.5.2 Market Share by Region, 2026 & 2036 (%)
5.6 Immunology
5.6.1 Market Size by Region, 2026-2036 (US$ Billion)
5.6.2 Market Share by Region, 2026 & 2036 (%)
5.7 Respiratory
5.7.1 Market Size by Region, 2026-2036 (US$ Billion)
5.7.2 Market Share by Region, 2026 & 2036 (%)
5.8 Others
5.8.1 Market Size by Region, 2026-2036 (US$ Billion)
5.8.2 Market Share by Region, 2026 & 2036 (%)

6 Decentralised Clinical Trials Market Analysis by Technology
6.1 Key Findings
6.2 Technology Segment: Market Attractiveness Index
6.3 Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
6.4 Telemedicine
6.4.1 Market Size by Region, 2026-2036 (US$ Billion)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Mobile Healthcare
6.5.1 Market Size by Region, 2026-2036 (US$ Billion)
6.5.2 Market Share by Region, 2026 & 2036 (%)
6.6 Wearable Devices
6.6.1 Market Size by Region, 2026-2036 (US$ Billion)
6.6.2 Market Share by Region, 2026 & 2036 (%)
6.7 Web-based Technology
6.7.1 Market Size by Region, 2026-2036 (US$ Billion)
6.7.2 Market Share by Region, 2026 & 2036 (%)
6.8 Others
6.8.1 Market Size by Region, 2026-2036 (US$ Billion)
6.8.2 Market Share by Region, 2026 & 2036 (%)

7 Decentralised Clinical Trials Market Analysis by End-User
7.1 Key Findings
7.2 End-User Segment: Market Attractiveness Index
7.3 Decentralised Clinical Trials Market Size Estimation and Forecast by End-User
7.4 Pharmaceutical and Biopharmaceutical Companies
7.4.1 Market Size by Region, 2026-2036 (US$ Billion)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Clinical Research Organisations (CROs)
7.5.1 Market Size by Region, 2026-2036 (US$ Billion)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Others
7.6.1 Market Size by Region, 2026-2036 (US$ Billion)
7.6.2 Market Share by Region, 2026 & 2036 (%)

8 Decentralised Clinical Trials Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Decentralised Clinical Trials Market Analysis
9.1 Key Findings
9.2 North America Decentralised Clinical Trials Market Attractiveness Index
9.3 North America Decentralised Clinical Trials Market by Country, 2025, 2031 & 2036 (US$ Billion)
9.4 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
9.5 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
9.6 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
9.7 North America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
9.8 North America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
9.9 U.S. Decentralised Clinical Trials Market Analysis
9.10 Canada Decentralised Clinical Trials Market Analysis

10 Europe Decentralised Clinical Trials Market Analysis
10.1 Key Findings
10.2 Europe Decentralised Clinical Trials Market Attractiveness Index
10.3 Europe Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
10.4 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Country
10.5 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
10.6 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
10.7 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
10.8 Europe Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
10.9 Germany Decentralised Clinical Trials Market Analysis
10.10 France Decentralised Clinical Trials Market Analysis
10.11 UK Decentralised Clinical Trials Market Analysis
10.12 Italy Decentralised Clinical Trials Market Analysis
10.13 Spain Decentralised Clinical Trials Market Analysis
10.14 Russia Decentralised Clinical Trials Market Analysis
10.15 Poland Decentralised Clinical Trials Market Analysis
10.16 Belgium Decentralised Clinical Trials Market Analysis
10.17 Switzerland Decentralised Clinical Trials Market Analysis
10.18 Netherland Decentralised Clinical Trials Market Analysis
10.19 Rest of Europe Decentralised Clinical Trials Market Analysis

11 Asia Pacific Decentralised Clinical Trials Market Analysis
11.1 Key Findings
11.2 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
11.3 Asia Pacific Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
11.4 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Country
11.5 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
11.6 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
11.7 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
11.8 Asia Pacific Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
11.9 Japan Decentralised Clinical Trials Market Analysis
11.10 China Decentralised Clinical Trials Market Analysis
11.11 India Decentralised Clinical Trials Market Analysis
11.12 Australia Decentralised Clinical Trials Market Analysis
11.13 South Korea Decentralised Clinical Trials Market Analysis
11.14 Singapore Decentralised Clinical Trials Market Analysis
11.15 Taiwan Decentralised Clinical Trials Market Analysis
11.16 New Zealand Decentralised Clinical Trials Market Analysis
11.17 Malaysia Decentralised Clinical Trials Market Analysis
11.18 Rest of Asia Pacific Decentralised Clinical Trials Market Analysis

12 Latin America Decentralised Clinical Trials Market Analysis
12.1 Key Findings
12.2 Latin America Decentralised Clinical Trials Market Attractiveness Index
12.3 Latin America Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
12.4 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Country
12.5 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
12.6 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
12.7 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
12.8 Latin America Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
12.9 Brazil Decentralised Clinical Trials Market Analysis
12.10 Mexico Decentralised Clinical Trials Market Analysis
12.11 Argentina Decentralised Clinical Trials Market Analysis
12.12 Colombia Decentralised Clinical Trials Market Analysis
12.13 Chile Decentralised Clinical Trials Market Analysis
12.14 Rest of Latin America Decentralised Clinical Trials Market Analysis

13 MEA Decentralised Clinical Trials Market Analysis
13.1 Key Findings
13.2 MEA Decentralised Clinical Trials Market Attractiveness Index
13.3 MEA Decentralised Clinical Trials Market by Country, 2026, 2031 & 2036 (US$ Billion)
13.4 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Country
13.5 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Study Design
13.6 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Indication
13.7 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by Technology
13.8 MEA Decentralised Clinical Trials Market Size Estimation and Forecast by End-users
13.9 GCC Decentralised Clinical Trials Market Analysis
13.10 South Africa Decentralised Clinical Trials Market Analysis
13.11 Egypt Decentralised Clinical Trials Market Analysis
13.12 Rest of MEA Decentralised Clinical Trials Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2024
14.2 Strategic Outlook
14.3 4G Clinical
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.3.4 Strategic Outlook
14.4 Advarra Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Strategic Outlook
14.5 Castor
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Solutions Benchmarking
14.5.4 Strategic Outlook
14.6 Clario
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Solutions Benchmarking
14.6.4 Strategic Outlook
14.7 Clinical Ink
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Solutions Benchmarking
14.7.4 Strategic Outlook
14.8 Cloudzbyz, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Dassault Systemes SE (Medidata Solutions, Inc.)
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2021-2024
14.9.3.2 R&D, 2021-2024
14.9.3.3 Regional Market Shares, 2024
14.9.3.4 Business Segment Market Shares, 2024
14.9.4 Product Benchmarking
14.9.5 SWOT Analysis
14.9.6 Strategic Outlook
14.10 Ergomed Group
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 Florence Healthcare, Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Strategic Outlook
14.12 Icon Plc
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2021-2024
14.12.3.2 Regional Market Shares, 2024
14.12.4 Product Benchmarking
14.12.5 SWOT Analysis
14.12.6 Strategic Outlook
14.13 Iqvia Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2022-2025
14.13.3.2 Regional Market Shares, 2024
14.13.3.3 Business Segment Market Shares, 2025
14.13.4 Product Benchmarking
14.13.5 SWOT Analysis
14.13.6 Strategic Outlook
14.14 KORE Wireless Group, Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2021-2024
14.14.3.2 Regional Market Shares, 2024
14.14.3.3 Business Segment Market Shares, 2024
14.14.4 Product Benchmarking
14.14.5 SWOT Analysis
14.14.6 Strategic Outlook
14.15 Labcorp Holdings
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2022-2025
14.15.3.2 Regional Market Shares, 2024
14.15.3.3 Business Segment Market Shares, 2024
14.15.4 Product Benchmarking
14.15.5 SWOT Analysis
14.15.6 Strategic Outlook
14.16 Medable Inc.
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Product Benchmarking
14.16.4 Strategic Outlook
14.17 Medrio, Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Product Benchmarking
14.17.4 Strategic Outlook
14.18 Novotech Health Holdings
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Product Benchmarking
14.18.4 Strategic Outlook
14.19 Oracle Corporation (Oracle Life Sciences)
14.19.1 Company Snapshot
14.19.2 Company Overview
14.19.3 Financial Analysis
14.19.3.1 Net Revenue, 2022-2025
14.19.3.2 R&D, 2022-2025
14.19.3.3 Regional Market Shares, 2024
14.19.3.4 Business Segment Market Shares, 2024
14.19.4 Product Benchmarking
14.19.5 SWOT Analysis
14.19.6 Strategic Outlook
14.20 Parexel International (MA) Corporation
14.20.1 Company Snapshot
14.20.2 Company Overview
14.20.3 Product Benchmarking
14.20.4 SWOT Analysis
14.20.5 Strategic Outlook
14.21 ProPharma Group MIS Limited
14.21.1 Company Snapshot
14.21.2 Company Overview
14.21.3 Product Benchmarking
14.21.4 Strategic Outlook
14.22 Science 37 Holdings, Inc.
14.22.1 Company Snapshot
14.22.2 Company Overview
14.22.3 Product Benchmarking
14.22.4 Strategic Outlook
14.23 Signant Health
14.23.1 Company Snapshot
14.23.2 Company Overview
14.23.3 Product Benchmarking
14.23.4 Strategic Outlook
14.24 Syneos Health
14.24.1 Company Snapshot
14.24.2 Company Overview
14.24.3 Product Benchmarking
14.24.4 Strategic Outlook
14.25 Thermo Fisher Scientific Inc.
14.25.1 Company Snapshot
14.25.2 Company Overview
14.25.3 Financial Analysis
14.25.3.1 Net Revenue, 2022-2025
14.25.3.2 R&D, 2022-2025
14.25.3.3 Regional Market Shares, 2024
14.25.3.4 Business Segment Market Shares, 2024
14.25.4 Product Benchmarking
14.25.5 SWOT Analysis
14.25.6 Strategic Outlook
14.26 TFS HealthScience
14.26.1 Company Snapshot
14.26.2 Company Overview
14.26.3 Product Benchmarking
14.26.4 Strategic Outlook
14.27 THREAD Research
14.27.1 Company Snapshot
14.27.2 Company Overview
14.27.3 Product Benchmarking
14.27.4 Strategic Outlook
14.28 Veeva Systems Inc.
14.28.1 Company Snapshot
14.28.2 Company Overview
14.28.3 Financial Analysis
14.28.3.1 Net Revenue, 2022-2025
14.28.3.2 R&D, 2021-2024
14.28.3.3 Regional Market Shares, 2025
14.28.3.4 Business Segment Market Shares, 2025
14.28.4 Product Benchmarking
14.28.5 SWOT Analysis
14.28.6 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Decentralised Clinical Trials Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
Table 3 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
Table 4 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
Table 5 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 6 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 7 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 8 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 9 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 10 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 11 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 12 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 15 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 16 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 17 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 18 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 19 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 20 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 21 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 22 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 23 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 25 Decentralised Clinical Trials Market Forecast by Region, 2026-2036 (US$ Million, AGR%, CAGR%)
Table 26 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 39 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 44 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 45 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 46 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 47 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 48 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 54 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 55 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 56 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 57 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 58 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 59 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 60 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 61 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 62 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 68 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 69 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 70 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 71 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 72 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 73 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 74 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 75 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 77 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Decentralised Clinical Trials Market Forecast by Technlogy, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 80 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 81 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 82 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 83 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 4G Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 4G Clinical: Product Benchmarking
Table 87 4G Clinical: Strategic Outlook
Table 88 Advarra Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Advarra Inc.: Product Benchmarking
Table 90 Advarra: Strategic Outlook
Table 91 Castor: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Castor: Solutions Benchmarking
Table 93 Castor: Strategic Outlook
Table 94 Clario: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Clario: Solutions Benchmarking
Table 96 Clario: Strategic Outlook
Table 97 Clinical Ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Clinical Ink: Solutions Benchmarking
Table 99 Clinical Ink: Strategic Outlook
Table 100 Cloudzbyz, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Cloudzbyz, Inc.: Product Benchmarking
Table 102 Cloudzbyz, Inc.: Strategic Outlook
Table 103 Dassault Systemes SE (Medidata Solutions, Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dassault Systemes SE (Medidata Solutions, Inc.): Product Benchmarking
Table 105 Dassault Systemes SE (Medidata Solutions, Inc.): SWOT Analysis
Table 106 Dassault Systemes SE (Medidata Solutions, Inc.): Strategic Outlook
Table 107 Ergomed Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Ergomed Group: Product Benchmarking
Table 109 Ergomed Group: Strategic Outlook
Table 110 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Florence Healthcare, Inc.: Product Benchmarking
Table 112 Florence Healthcare, Inc.: Strategic Outlook
Table 113 Icon Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Icon Plc: Product Benchmarking
Table 115 Icon Plc: SWOT Analysis
Table 116 Icon Plc: Strategic Outlook
Table 117 Iqvia Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Iqvia Inc.: Product Benchmarking
Table 119 Iqvia Inc.: SWOT Analysis
Table 120 Iqvia Inc.: Strategic Outlook
Table 121 KORE Wireless Group, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 KORE Wireless Group, Inc.: Product Benchmarking
Table 123 KORE Wireless Group, Inc.: SWOT Analysis
Table 124 KORE Wireless Group, Inc.: Strategic Outlook
Table 125 Labcorp Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Labcorp Holdings: Product Benchmarking
Table 127 Labcorp Holdings: SWOT Analysis
Table 128 Labcorp Holdings: Strategic Outlook
Table 129 Medable Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Medable Inc.: Product Benchmarking
Table 131 Medable Inc.: Strategic Outlook
Table 132 Medrio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Medrio, Inc.: Product Benchmarking
Table 134 Medrio, Inc.: Strategic Outlook
Table 135 Novotech Health Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Novotech Health Holdings: Product Benchmarking
Table 137 Novotech Health Holdings: Strategic Outlook
Table 138 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Oracle Life Sciences: Product Benchmarking
Table 140 Oracle Life Sciences: SWOT Analysis
Table 141 Oracle Corporation: Strategic Outlook
Table 142 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Parexel International (MA) Corporation: Product Benchmarking
Table 144 Parexel International (MA) Corporation: SWOT Analysis
Table 145 Parexel International (MA) Corporation: Strategic Outlook
Table 146 ProPharma Group MIS Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 ProPharma Group MIS Limited: Product Benchmarking
Table 148 ProPharma Group MIS Limited: Strategic Outlook
Table 149 Science 37 Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Science 37 Holdings, Inc.: Product Benchmarking
Table 151 Science 37 Holdings, Inc.: Strategic Outlook
Table 152 Signant Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Signant Health: Product Benchmarking
Table 154 Signant Health: Strategic Outlook
Table 155 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Syneos Health: Product Benchmarking
Table 157 Syneos Health: Strategic Outlook
Table 158 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 160 Thermo Fisher Scientific Inc.: SWOT Analysis
Table 161 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 162 TFS HealthScience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 TFS HealthScience: Product Benchmarking
Table 164 TFS HealthScience: Strategic Outlook
Table 165 THREAD Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 THREAD Research: Product Benchmarking
Table 167 THREAD Research: Strategic Outlook
Table 168 Veeva Systems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Veeva Systems Inc.: Product Benchmarking
Table 170 Veeva Systems Inc.: SWOT Analysis
Table 171 Veeva Systems Inc.: Strategic Outlook

List of Figures
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Study-Design: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market by Region: Market Attractiveness Index
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market: Impact Analysis
Figure 9 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 16 Decentralised Clinical Trials Market: PEST Analysis
Figure 17 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 18 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 19 Decentralised Clinical Trials Market Share Forecast by Study Design, 2026, 2031, 2036 (%)
Figure 20 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 21 Interventional Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 22 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 Observational Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 Expanded Access Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 27 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 28 Decentralised Clinical Trials Market Share Forecast by Indication, 2026, 2031, 2036 (%)
Figure 29 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 30 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 31 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 32 Cardiovascular Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 34 Immunology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Respiratory Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 38 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 40 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 41 Decentralised Clinical Trials Market Share Forecast by Technology, 2026, 2031, 2036 (%)
Figure 42 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 43 Telemedicine Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 45 Mobile Healthcare Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 47 Wearable Devices Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Web-based Technology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Decentralised Clinical Trials Market by End-User: Market Attractiveness Index
Figure 53 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR %)
Figure 54 Decentralised Clinical Trials Market Share Forecast by End-User, 2026, 2031, 2036 (%)
Figure 55 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 56 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 58 Clinical Research Organisations (CROs) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Decentralised Clinical Trials Market Forecast by Region 2025 and 2036 (Revenue, CAGR%)
Figure 62 Decentralised Clinical Trials Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 63 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %)
Figure 64 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 65 North America Decentralised Clinical Trials Market by Region, 2025, 2031 & 2036 (US$ Billion)
Figure 66 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 67 North America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 68 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 69 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 70 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 71 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 72 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 73 North America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 74 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 75 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 76 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 77 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 78 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 79 Europe Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 80 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 81 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 82 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 83 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 84 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 85 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 86 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 87 Europe Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 88 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 89 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 90 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 91 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 92 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 93 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 94 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 95 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 96 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 97 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 98 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 99 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 100 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 102 Asia Pacific Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 106 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 107 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 108 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 109 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 110 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 111 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 112 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 113 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 114 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 115 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 116 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 117 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 118 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 119 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 120 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 121 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 124 Latin America Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 125 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 126 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 127 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 128 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 129 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 130 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 131 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 132 Latin America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 133 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 134 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 135 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 136 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 137 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 138 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 139 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 142 MEA Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 143 MEA Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 144 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 145 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 146 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 147 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 148 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 149 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 150 MEA Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 151 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 152 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 153 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 154 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 155 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 156 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 157 Decentralised Clinical Trials Market: Company Share/Ranking, 2024
Figure 158 Dassault Systemes SE (Medidata Solutions, Inc.): Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 159 Dassault Systemes SE (Medidata Solutions, Inc.): R&D, 2021-2024 (US$ Million, AGR%)
Figure 160 Dassault Systemes SE (Medidata Solutions, Inc.): Regional Market Shares, 2024
Figure 161 Dassault Systemes SE (Medidata Solutions, Inc.): Business Segment Market Shares, 2024
Figure 162 Icon Plc: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 163 Icon Plc: Regional Market Shares, 2024
Figure 164 Iqvia Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 165 Iqvia Inc.: Regional Market Shares, 2024
Figure 166 Iqvia Inc.: Business Segment Market Shares, 2025
Figure 167 KORE Wireless Group, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 168 KORE Wireless Group, Inc.: Regional Market Shares, 2024
Figure 169 KORE Wireless Group, Inc.: Business Segment Market Shares, 2024
Figure 170 Labcorp Holdings: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 171 Labcorp Holdings: Regional Market Shares, 2024
Figure 172 Labcorp Holdings: Business Segment Market Shares, 2024
Figure 173 Oracle Life Sciences: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 174 Oracle Life Sciences: R&D, 2022-2025 (US$ Million, AGR%)
Figure 175 Oracle Life Sciences: Regional Market Shares, 2025
Figure 176 Oracle Life Sciences: Business Segment Market Shares, 2025
Figure 177 Thermo Fisher Scientific Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 178 Thermo Fisher Scientific Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 179 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
Figure 180 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2024
Figure 181 Veeva Systems Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 182 Veeva Systems Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 183 Veeva Systems Inc.: Regional Market Shares, 2025
Figure 184 Veeva Systems Inc.: Business Segment Market Shares, 2025

List of Companies Profiled in the Report
4G Clinical
Advarra Inc.
Castor EDC
Clario
Clinical Ink, Inc.
CLOUDZBY, INC.
Dassault Systemes SE (Medidata Solutions, Inc.)
Ergomed Group
Florence Healthcare, Inc.
ICON PLC
IQVIA Inc.
Kore Wireless Group Inc.
Labcorp Drug Development
Medable, Inc.
Medrio Inc.
Novo Health Holdings
Oracle Corporation
Parexel International Corporation
ProPharma Group MIS Limited
Science 37
Signant Health
Syneos Health
TFS HealthScience
Thermo Fischer Scientific
Thread Research
Veeva Systems

List of Other Companies Mentioned in the Report
Acrostar
ADAMAS Consulting
Amazon Bedrock
Amazon Web Services Inc.
ArtiQ, Inc.
Avio S.p.A.
Berlinger & Co. AG
BioReference Health, LLC
Biostar
Boehringer Ingelheim
CareMetx, Inc.
Catalent
Cerberus Capital Management
Chugai Pharmaceutical Co., Ltd.
Clario
Clario Holdings, Inc.
Clinical Ink
Cogstate Ltd.
C Tech, Inc.
Emsere, Inc.
Evolvics
Fascicolo Sanitario Elettronico (FSE)
Google
Hawthorne Effect, Inc.
IgniteData Ltd.
iRhythm Technologies
Jaguar Land Rover Limited
Labcorp Drug Development
Labshares, Inc.
Medical Guardian
Medsafe
Microsoft
Microsoft Inc.
Mistral AI, Inc.
Mobilise-D
Mural Health Technologies
NeuroRx, Inc.
Noss Research Consulting, LLC
Novartis
NVIDIA Corporation
Olink Holding AB
Oncomatryx
OpenAI, Inc.
Ouro Medicines Inc.
Palantir Technologies Inc.
Panacea, Inc.
Paradigm Health, Inc.
Parexel
PathAI, Inc.
PBL Technology Ltd
Pfizer
PrimeVigilance Limited
Providence
QbD Group
Radialogica AB
SEQSTER Inc.
SK Life Science, Inc.
SPRIM PRO
Tandem Diabetes Care, Inc.
Tipalti, Inc.
WCG Clinical, Inc.
Weave Bio, Inc.

List of Associations Mentioned in the Report
Agência Nacional de Vigilância Sanitária (ANVISA)
Center for Drug Evaluation (CDE)
Central Drugs Standard Control Organization (CDSCO)
China National Medical Products Administration (NMPA)
Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
Dutch Clinical Research Foundation (DCRF)
Egyptian Drug Authority (EDA)
European Medicines Agency (EMA)
GEOVIA
Health Sciences Authority (HSA), Singapore
Indonesia Clinical Research Centre
Instituto de Salud Pública (ISP)
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)
Israel Ministry of Health
Japanese Foundation for Cancer Research
Japanese Society for Inherited Metabolic Diseases
Korea Health Industry Development Institute (KHIDI)
Kyushu University Hospital, Japan
Malaysian Guideline for Application of Clinical Trial Import Licence (CTIL)
Medicines and Healthcare products Regulatory Agency (MHRA), UK
MICIN
Ministry of Food and Drug Safety (MFDS), South Korea
Ministry of Health (MOH), Malaysia
Ministry of Health and Population, Egypt
Ministry of Health, Labour and Welfare (MHLW), Japan
National Cancer Center Hospital (NCCH)
National Department of Health, South Africa
National Pharmaceutical Regulatory Agency (NPRA)
National Pharmaceutical Regulatory Agency (NPRA), Malaysia
NEUCA
NIHR (National Institute for Health and Care Research), UK
Osaka Medical and Pharmaceutical University (OMPU)
Peru National Institute of Health (INS)
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Research Ethics Committees (CEPs)
Saudi Food and Drug Authority (SFDA)
Saudi National Institute of Health (Saudi NIH)
SEHA virtual hospital
South African Health Products Regulatory Authority (SAHPRA)
START Center for Cancer Research
Taiwan Alliance of Clinical Trial Centers (TACTC)
Taiwan Food and Drug Administration (TFDA)
Tufts Center for the Study of Drug Development
Turkish Medicines and Medical Devices Agency (TITCK)
U.S. FDA
UAE MOHAP
Unified State Health Information System (EGISZ), Russia
University of Oxford NeuroMetrology Laboratory
UZ Leuven
World Health Organization (WHO)
Wonju Severance Christian Hospital